Bristol-Myers Squibb Co P/B Ratio
Data as of August 04, 2026
P/B Ratio
7.13
Stock Price
$65.47
Book Value/Share
$9.18
Sector
Pharmaceuticals
How It's Calculated
7.13 = $65.47 ÷ $9.18
What This Means
Bristol-Myers Squibb Co's P/B ratio of 7.13 is above 6. Asset-light business models and unrecognized intangible assets can make book value a limited denominator; the multiple alone does not determine fair value.
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Co (BMY) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $133.41B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $65.47, within a 52-week range of $42.52 to $65.66 (-0.3% from the high, +54.0% from the low). Beta of 0.23 indicates relatively lower volatility versus the market.
Trailing profit margin is about 12.3%, signaling a solid profit margin for its industry.
Understanding This Metric
The price-to-book ratio compares market price to net asset value per share. For Bristol-Myers Squibb Co, P/B is especially useful when earnings are volatile or temporarily depressed. In Pharmaceuticals, asset-heavy business models often anchor closer to book value, while asset-light models may trade far above book.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Bristol-Myers Squibb Co's P/B ratio of 7.13 can be compared with peers such as LLY (39.93), JNJ (7.51), MRK (6.01). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- BMY is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.23 suggests lower-than-market price sensitivity.
- Trailing profit margin of 12.3% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for BMY.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other BMY Metrics
Frequently Asked Questions
What does BMY's price-to-book ratio indicate?
P/B compares share price to book value per share. Bristol-Myers Squibb Co's P/B of 7.13 reflects how the market prices net assets — especially relevant for asset-heavy Pharmaceuticals business models.
Is 7.13 above or below book value?
A P/B above 1.0 (7.13) means the market values BMY above accounting book value — often due to brands, growth, or intangible assets.
How does P/B compare within Pharmaceuticals?
Peer P/B levels in Pharmaceuticals (e.g. LLY (39.93), JNJ (7.51), MRK (6.01)) provide context; asset-light vs asset-heavy models differ materially.
Calculate the p/b ratio for any stock with our free calculator.
Open P/B Ratio Calculator →